ARTICLE | Company News
NephroGenex, Biomedical Research Foundation, Karolinska Institute deal
May 16, 2005 7:00 AM UTC
NephroGenex acquired exclusive commercialization rights to the foundation's inhibitors of goodpasture antigen binding protein (GPBP) kinase. High levels of the kinase are associated with inflammatory ...